BioCurate’s new “Proof of Concept” funding to help accelerate research into targeted cancer therapies
The first award under BioCurate’s new “Proof of Concept” fund has been granted to the Monash Biomedicine Discovery Institute (BDI). This award will support the key research needed to determine the effectiveness of targeting two proteins that could lead to novel, targeted treatments for triple negative breast cancer (TNBC) and other poor prognosis cancers.
The research, led by Professor Roger Daly, who heads the BDI’s cancer program, has already identified two proteins that are required by TNBC cells to grow. These proteins represent potential targets for small molecule drugs that could be used to treat this type of cancer.
BioCurate and Monash University accelerate research into targeted treatments for triple negative breast cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.